Venous leg ulcerations: A treatment update

Current Treatment Options in Cardiovascular Medicine

Volumn 12, Issue 2, 2010, Pages 101-116

  Farah, Ronda S ^a   Davis, Mark D P ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; CEFALEXIN; CIMETIDINE; CLINDAMYCIN; DAFLON; DICOUMAROL; HERBACEOUS AGENT; HORSE CHESTNUT SEED EXTRACT; LEVOFLOXACIN; LITHIUM; MONOETHANOLAMINE OLEATE; MORRHUATE SODIUM; PENTOXIFYLLINE; PLACEBO; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TETRADECYL SULFATE SODIUM; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ARTERIAL INSUFFICIENCY; BLEEDING; BODY POSITION; CELL PROLIFERATION; CELLULITIS; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; COMPRESSION BANDAGE; COMPRESSION GARMENT; COMPRESSION THERAPY; CONGESTIVE HEART FAILURE; CONTACT DERMATITIS; COORDINATION DISORDER; COST EFFECTIVENESS ANALYSIS; CYANOSIS; DAILY LIFE ACTIVITY; DEBRIDEMENT; DEEP VEIN THROMBOSIS; DEPRESSION; DIARRHEA; DRUG DOSE COMPARISON; DRUG EFFICACY; EDEMA; ERYTHEMA; FOAM DRESSING; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL TOXICITY; GAUZE DRESSING; HEALTH CARE COST; HEART FAILURE; HEMATOMA; HUMAN; HYDROCOLLOID DRESSING; HYDROGEL DRESSING; HYDROSTATIC PRESSURE; HYPERBARIC OXYGEN; INTERMITTENT CLAUDICATION; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; ISCHEMIA; KIDNEY FAILURE; LASER SURGERY; LEG ULCER; LIVER CIRRHOSIS; MUSCLE TWITCH; NAUSEA; NEURALGIA; NEUROTOXICITY; ORTHOTICS; OUTCOME ASSESSMENT; PARALYSIS; PATIENT COUNSELING; PHLEBITIS; PNEUMATIC TOOL; POSTTHROMBOSIS SYNDROME; PUPIL DISEASE; PURPURA; QUALITY OF LIFE; REVIEW; SAPHENOUS SURGERY; SCLEROTHERAPY; SIDE EFFECT; SKIN BRUISING; SKIN INJURY; SKIN NECROSIS; SKIN TOXICITY; SPLIT THICKNESS SKIN GRAFT; STUPOR; SUBFACIAL ENDOSCOPIC PERFORATING VEIN SURGERY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCER; VACUUM ASSISTED CLOSURE; VARICOSIS; VASCULITIS; VEIN INSUFFICIENCY; VEIN PERFORATION; VEIN PROSTHESIS; VENOUS REFLUX; VOMITING; WEAKNESS; WEIGHT REDUCTION; WOUND DRESSING; WOUND HEALING; WOUND INFECTION;

EID: 77953537260     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-010-0066-9     Document Type: Review

References (58)

1. Phillips T, Stanton B, Provan A, Lew R: A study of the impact of leg ulcers on quality of life: financial, social and psychological implications. J Am Acad Dermatol 1994, 31(1):49-53.
2. Bergqvist D, Lindholm C, Nelzén O: Chronic leg ulcers: the impact of venous disease. J Vasc Surg 1999, 29:752-755.
3. Callam M, Ruckley C, Harper D, et al.: Chronic ulceration of the leg: extent of the problem and provision of care. Br J Med 1985, 290:1855-1856.
4. Bickers DR: The burden of skin diseases: 2004: a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 2006, 55(3):490-500.
5. Davis MDP: Leg ulcerations. In Dermatological Signs of Internal Disease. Edited by Callen JP, Jorizzo JL, Bolognia JL, et al. Philadelphia: WB Saunders; 2009:381-399.
6. Burnand KG, Whimster I, Naidoo A, et al.: Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. Br Med J 1982, 285(6348):1071-1072.
7. Thomas PR, Nas GB, Dormandy JA: White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J (Clin Res Ed) 1988, 296(6638):1693-1695.
8. Bradbury AW, Murie JA, Ruckley CV: Role of the leukocyte in the pathogenesis of vascular disease. Br J Surg 1993, 80(12):1503-1512.
9. O'Meara S, Cullum NA, Nelson EA: Compression for venous leg ulcers. Cochrane Database Syst Rev 2009, CD000265.
10. Choucair M, Phillips TJ: Compression therapy. Dermatol Surg 1998, 24(1):141-148.
11. Weir D: Pearls of compression. In Wound Healing. Edited by Falabella AF, Kirsner RS. Boca Raton, FL: Taylor & Francis Group; 2005:423-437.
12. Schainfeld RM: Chronic venous insufficiency. Curr Treat Options Cardiovasc Med 2003, 5:109-119.
13. Donaldson MC: Chronic venous insufficiency. Curr Treat Options Cardiovasc Med 2000, 2:265-272.
14. Etufugh CN, Philips TJ: Venous ulcers. Clin Dermatol 2007, 25:121-130. This article includes a review of the pathophysiology, diagnosis, and treatment of venous ulcers. Treatment options discussed include medications, biologic skin substitutes, dressings, débridement, and surgical procedures.
15. Nelson EA, Mani R, Vowden K: Intermittent pneumatic compression for treating venous leg ulcers. Cochrane Database Syst Rev 2008, CD001899.
16. Amsler F, Willenberg T, Blattler W: In search of optimal compression therapy for venous leg ulcers: a meta-analysis of studies comparing divers bandages with specifically designed stockings. J Vasc Surg 2009, 50(3):668-674.
17. Falanga V, Fuijtani RM, Diaz C, et al.: Systemic treatment of venous leg ulcers with high doses of pentoxifylline: efficacy in a randomized, placebocontrolled trial. Wound Repair Regen 1999, 7 (4):208-213.
18. Jull A, Arroll B, Parag V, Waters J: Pentoxifylline for treating venous leg ulcers. Cochrane Database Sys Rev 2007, CD001733.
19. Guilhou JJ, Dereure O, Marzin L, et al.: Efficacy of Daflon (R) 500 mg in venous leg ulcer healing: a double blind randomized, controlled versus placebo trial in 107 patients. Angiology 1997, 48:77-85.
20. Guillot B, Guilhou JJ, de Chamvallins M, et al.: A long term treatment with a venotropic drug. Int Angiol 1989, 8(Suppl 4):67-71.
21. Smith PC: Daflon 500 mg and venous leg ulcer: new results from a meta-analysis. Angiology 2005, 56 (Suppl 1):S33.
22. O'Meara S, Al-Kurdi D, Ovington LG: Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev 2008, CD003557.
23. Brem H, Kirsner RS, Falanga V: Protocol for the successful treatment of venous ulcers. Am J Surg 2004, 1S-8S. (Pubitemid 38829760)
24. Davis MDP: Leg ulcerations. In Vascular Medicine and Endovascular Interventions. Edited by Rooke TW, Sullivan TM, Jaff MR. Columbia, MD: Society for Vascular Medicine and Biology; 2007:141-148.
25. Natural Medicines Comprehensive Database. Available at http://www.naturaldatabase.com. Accessed November 2009.
26. Pittler MH, Ernst E: Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev 2006, CD003230.
27. Leach MJ, Pincombe J, Foster G: Clinical efficacy of horsechestnut seed extract in the treatment of venous ulceration. J Wound Care 2006, 15(4):159-167.
28. Rathbun SW, Kirkpatrick AC: Treatment of chronic venous insufficiency. Curr Treat Options Cardiovasc Med 2007, 9:115-126.
29. Leach KJ, Pincombe J, Foster G: Using horsechestnut seed extract in the treatment of venous leg ulcers: a cost benefit analysis. Ostomy Wound Manage 2006, 52(4):68-70, 72-74, 76-78.
30. Cardinal M, Eisenbud DE, Armstrong DG, et al.: Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Rep Reg 2009, 17:306-311. This article is a retrospective study analyzing results from two previously conducted prospective trials on the treatment of venous leg and diabetic foot ulcers. The aim was to determine whether a correlation exists between wound healing outcomes and serial débridement. The results suggest that serial débridement increases rates of wound healing and closure.
31. Williams D, Stuart E, Miller D, et al.: Effect of sharp debridement using curette on recalcitrant nonhealing venous leg ulcers: a concurrently controlled, prospective cohort study. Wound Rep Reg 2005, 13:131-137.
32. Barwell JR, Davies CE, Deacon J, et al.: Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomized controlled trial. Lancet 2004, 363:1859-11854
33. Gohel MS, Barnwell JR, Taylor M, et al.: Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomized controlled trial. BMJ 2007, 335(7610):83. In this randomized controlled trial of 500 patients assigned to compression or compression plus saphenous surgery, surgical correction of superficial venous reflux plus compression bandaging reduced the recurrence of ulcers at 4 years and increased ulcer free time.
34. Chong TW, Bott MJ, Kern JA, et al.: Subfascial endoscopic perforating vein surgery (SEPS) for the treatment of venous ulcers. Ostomy Wound Manage 2005, 51(9):26-31.
35. Luebke T, Brunkwall J: Meta-analysis of subfascial endoscopic perforator vein surgery (SEPS) for chronic venous insufficiency. Phlebology 2009, 24 (1):8-16.
36. Tenbrook JA, Iafrati MD, O'Donnell TF, et al.: Systematic review of outcomes after surgical endoscopic perforator surgery. J Vasc Surg 2004, 39(3):583-589.
37. Nijsten Y, van den Bos RR, Goldman MP, et al.: Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol 2009, 60(1):110-119.
38. Bergan JJ, Pascarella L: Severe chronic venous insufficiency: primary treatment with sclerofoam. Semin Vasc Surg 2005, 8(1):49-56.
39. O'Hare JL, Vandenbroeck C, Earnshaw JJ: Randomized pilot trial of early foam sclerotherapy for venous leg ulcers. Br J Surg 2009, 96(Suppl 1):15.
40. Hertzman PA, Owens R: Rapid healing of chronic venous ulcers following ultrasound-guided foam sclerotherapy. Phlebology 2007, 22(1):34-39.
41. Gillet JL, Guedes JM, Guex JJ, et al.: Side-effects and complications of foam sclerotherapy for the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients. Phlebology 2009, 24(3):131-138.
42. Marston W: Evaluation and treatment of leg ulcers associated with chronic venous insufficiency. Clin Plast Surg 2007, 34(4):717-730.
43. Pavcnik D, Uchida B, Kaufman J, et al.: Percutaneous management of chronic deep venous reflux: review of experimental work and early clinical experience with bioprosthetic valve. Vasc Med 2008, 13(1):75-84.
44. Kirsner RS, Matta SM, Falanga V, et al.: Split thickness skin grafting of leg ulcers. J Dermatol Surg 1995, 21:701-703.
45. Abisi S,Tan J, Burnand KG: Excision and meshed skin grafting for leg ulcers resistant to compression therapy. Br J Surg 2007, 94:194-197.
46. Barber C, Watt A, Pham C, et al.: Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes. J Wound Care 2008, 17(120):517-527.
47. Fivenson D, Scherschun L: Clinical and economic impact of Apligraf for the treatment of nonhealing venous leg ulcers. Intl J Dermatol 2003, 42:960-965.
48. Curran MP, Plosker GL: Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. BioDrugs 2002, 16(6):439-455.
49. Falanga V, Sabolinski M: A bilayered skin construct (APLIGRAF) accelerates closure of hard-to-heal venous ulcers. Wound Repair Regen 1999, 7(4):201-207.
50. Enoch S: Recent advances and emerging treatments. BMJ 2006, 332(7547):962.
51. Da Costa RM, Ribeiro Jesus FM, Aniceto C, et al.: Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers. Wound Repair Regen 1999, 7 (1):17-25.
52. Jaschke E, Zabernigg A, Gattringer C: Recombinant human granulocyte-macrophage colonystimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers. Int J Dermatol 1999, 38 (5):380-386.
53. Margolis DJ, Morris LM, Papadopoulos M: Phase I study of H5.020CMV.PDGF-beta to treat venous leg ulcer disease. Mol Ther 2009, 17(10):1822-1829. This phase 1 study evaluated the safety and feasibility of periulcer injections of an adenoviral construct expressing PDGF-β to treat venous leg ulcer disease. Injections werewell tolerated and resulted in a decrease in overall wound size.
54. Argenta LC, Morykwas MJ: Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann Plast Surg 1997, 38(6):563-576.
55. Vuerstack JDD, Vainas T, Wuite J, et al.: State-of-theart treatment of chronic leg ulcers: a randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings. J Vasc Surg 2006, 44:1029-1038.
56. Roeckl-Wiedmann I, Bennett M, Kranke P: Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg 2005, 92(1):24-32.
57. Hammarlund C, Sundberg T: Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plast Reconstr Surg 1994, 93 (4):829-833.
58. Batora I, Batorova A, Zimanova J, et al.: The effect of hyperbaric oxygen therapy in the treatment of leg ulcers. Bratisl Lek Listy 2006, 107(1-2):40.